Viralytics Ltd S/Adr

(VRACY)

By |

Profile

Viralytics Ltd is incorporated in Australia. The Company is engaged in the clinical development of the product CAVATAK. This was achieved through progression of a Phase II US clinical study; completion and reporting of the single-dose Phase I intravenous study; progressing preclinical programs in cancer types including superficial bladder cancer and leukaemia; and enhancement of the intellectual property assets attached to the product. Its clinical program comprises trials using CAVATAK administered either intraveneously or directly into the tumour (intratumourally). CAVATAK is proposed mode of action is to kill both local tumour cells and distant metastatic cells, by direct cytolysis and by inducing an immune response to tumour cells.

Contact Information

Website: www.viralytics.com
Main Phone: +61 299884000
Address: 66 Hunter Street
Address 2: Suite 305, Level 3
State: NSW
City / Town: Sydney
Country: AUS
Postal Code: 2000

Issuer Information

Exchange: OTCQX
NAICS: Biological Product (except Diagnostic) Manufacturing(325414)
(%)
Company data no longer available
Last Price N/A Change $ N/A Change % N/A Tick N/A
Bid N/A Bid Size N/A Ask N/A Ask Size N/A
Open N/A High N/A Low N/A Prev Close N/A
Last Trade Volume 0 52 Wk Hi 4.10 52 Wk Low 1.50
Market Cap N/A Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 92,754,296.00 EPS (TTM) -0.14 PE Ratio N/A Exchange OTCQX
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 3 3 3 3
Low Target Price Estimate 3 3 3 3
Mean Target Price Estimate 3 3 3 3
Standard Deviation 0 0 0 0
Date of Most Recent Estimate 06/16/15 06/16/15 06/16/15 06/16/15
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 0 0 0 1
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 0 0 0 1